Global Animal Livestock Drugs Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Animal Livestock Drugs are a variety of drugs that are specially designed to cure diseases related to animal livestock such as cattle, sheep, goats, horses, and many others. These drugs are created for the diagnosis and prevention of diseases that occur in animal livestock to maintain good health. The rising incidences of zoonotic and food-borne diseases, growing investment in healthcare infrastructure development, rising government awareness for animal health, and increasing launch of animal livestock drugs by the leading market players are the several key factors stimulating the growth of the global market. For instance, in May 2022, The UK’s National Office of Animal Health (NOAH) proclaimed the introduction of the Livestock Vaccination Guideline. The objective of this guideline is to provide support to farmers and vets for improving the health and welfare of UK cattle and sheep. Also, maintain farm resilience and sustainable developments in productivity. Consequentially, rising government support and execution of several animal healthcare guidelines are surging the demand for animal livestock drugs, which is accelerating the market growth across the globe. However, the side effects of several drugs impede the growth of the market over the forecast period of 2022-2028. Also, the rising drug approvals and launches, along with growing research and development activities are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Animal Livestock Drugs Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing R&D activities by the leading market players and rising emphasis on animal livestock health. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing government awareness programs, as well as the growing prevalence of zoonotic and food-borne diseases, would create lucrative growth prospects for the Animal Livestock Drugs Market across the Asia-Pacific region.

Major market players included in this report are:
Zoetis Inc.
C.H. Boehringer Sohn AG & Ko. KG
Merck Animal Health Inc.
Elanco Animal Health Incorporated
Bayer HealthCare Animal Health Inc.
Ceva Sant? Animale
Virbac Group
Vetoquinol S.A.
IDEXX Laboratories, Inc.
Covetrus, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Cattle
Sheep
Goats
Horses
Others
By Product Type:
Vaccines
Antibiotics
Others
By End-users:
Veterinary Hospitals
Veterinary Specialty Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Animal Livestock Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors